CD4 and AIDS: The advent of HAART has led to a dramatic decline in AIDS-related morbidity and mortality by decreasing plasma viremia and increasing CD4+ T cell counts [11,12], normalizing the progenitor cell function [13] and restoring CD4+T-cell functions [14,15].